Chimeric Ad5 vectors expressing the short fiber of Ad41 show reduced affinity for human intestinal epithelium

Molecular Pharmaceutics

Volumn 2, Issue 6, 2005, Pages 500-508

  Kesisoglou, Filippos ^a   Chamberlain, Joel R ^b   Schmiedlin Ren, Phyllissa ^c   Kaz, Andrew ^c   Fleisher, David ^a   Roessler, Blake ^c   Zimmermann, Ellen M ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adenovirus; Cell culture; Enterocytes; Explants; Transduction

Indexed keywords

ADENOVIRUS VECTOR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; SHORT FIBER AD41 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOVIRUS 5; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL STRAIN CACO 2; CHIMERA; CHO CELL; COMPARATIVE STUDY; CONTROLLED STUDY; ESCHERICHIA COLI; EXPLANT; GENETIC ENGINEERING; GENETIC TRANSDUCTION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTESTINE BIOPSY; INTESTINE CELL; INTESTINE EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; TISSUE CULTURE; ULCERATIVE COLITIS; VIRUS RECOMBINANT; VIRUS RECOMBINATION; WESTERN BLOTTING; WOUND HEALING;

ADENOVIRUSES, HUMAN; CELL LINE; CELL LINE, TUMOR; GENOME, VIRAL; HUMANS; INTESTINAL MUCOSA; RECEPTORS, VIRUS; TRANSDUCTION, GENETIC; VIRUS REPLICATION;

EID: 29544436417     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp0498897     Document Type: Article

References (36)

1. Robbins, P. D.; Ghivizzani, S. C. Viral vectors for gene therapy. Pharmacol. Ther. 1998, 80, 35-47.
2. Benihoud, K.; Yeh, P.; Perricaudet, M. Adenovirus vectors for gene delivery. Curr. Opin. Biotechnol. 1999, 10, 440-447.
3. Bergelson, J. M. Receptors mediating adenovirus attachment and internalization. Biochem. Pharmacol. 1999, 57, 975-979.
4. Bergelson, J. M.; et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275, 1320-1323.
5. Tomko, R. P.; Xu, R.; Philipson, L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 3352-3356.
6. Wickham, T. J.; et al. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993, 73, 309-319.
7. Dechecchi, M. C.; et al. Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J. Virol. 2001, 75, 8772-8780.
8. Dechecchi, M. C.; et al. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology 2000, 268, 382-390.
9. Martin, K.; et al. Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism. Mol. Ther. 2003, 8, 485-494.
10. Koizumi, N.; et al. Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation. J. Virol. 2003, 77, 13062-13072.
11. Barnett, B. G.; Crews, C. J.; Douglas, J. T. Targeted adenoviral vectors. Biochim. Biophys. Acta 2002, 1575, 1-14.
12. Yeh, H. Y.; et al. Human adenovirus type 41 contains two fibers. Virus Res. 1994, 33, 179-198.
13. Favier, A. L.; et al. Structural studies of human enteric adenovirus type 41. Virology 2002, 293, 75-85.
14. Roelvink, P. W.; et al. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J. Virol. 1998, 72, 7909-7915.
15. Nicol, C. G.; et al. Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats. Mol. Ther. 2004, 10, 344-354.
16. Albinsson, B.; Kidd, A. H. Adenovirus type 41 lacks an RGD alpha(v)-integrin binding motif on the penton base and undergoes delayed uptake in A549 cells. Virus Res. 1999, 64, 125-136.
17. Wirtz, S.; Neurath, M. F. Inflammatory bowel disorders: gene therapy solutions. Curr. Opin. Mol. Ther. 2003, 5, 495-502.
18. Wirtz, S.; Neurath, M. F. Gene transfer approaches for the treatment of inflammatory bowel disease. Gene Ther. 2003, 10, 854-860.
19. Gerard, R. D.; Meidell, R. S. Adenovirus Vectors. In DNA Cloning: A Practical Approach; Glover, D. M., Hames, B. D., Eds.; Oxford University Press: Oxford, 1995; pp 285-305.
20. Chartier, C.; et al. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 1996, 70, 4805-4810.
21. Amalfitano, A.; Chamberlain, J. S. Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy. Gene Ther. 1997, 4, 258-263.
22. This footnote was deleted on revision.
23. Harvey, B. G.; et al. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. J. Virol. 1999, 73, 6729-6742.
24. Shayakhmetov, D. M.; et al. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector. J. Virol. 2000, 74, 2567-2583.
25. Schoggins, J. W.; Gall, J. G.; Falck-Pedersen, E. Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo. J. Virol. 2003, 77, 1039-1048.
26. Gall, J.; et al. Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. J. Virol. 1996, 70, 2116-2123.
27. Stevenson, S. C.; et al. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J. Virol. 1997, 71, 4782-4790.
28. Schroers, R.; et al. Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors. Exp. Hematol. 2004, 32, 536-546.
29. Nakamura, T.; Sato, K.; Hamada, H. Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber. J. Virol. 2003, 77, 2512-2521.
30. Kawakami, Y.; et al. Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication. Cancer Res. 2003, 63, 1262-1269.
31. Goossens, P. H.; et al. Infection efficiency of type 5 adenoviral vectors in synovial tissue can be enhanced with a type 16 fiber. Arthritis Rheum. 2001, 44, 570-577.
32. Kanerva, A.; et al. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. Clin. Cancer Res. 2002, 8, 275-280.
33. Mizuguchi, H.; Hayakawa, T. Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes. Gene 2002, 285, 69-77.
34. Croyle, M. A.; et al. Role of integrin expression in adenovirus-mediated gene delivery to the intestinal epithelium. Hum. Gene Ther. 1998, 9, 561-573.
35. Schmiedlin-Ren, P.; et al. Increased transduction of human intestinal epithelial cells by adenoviral vectors in inflammatory bowel disease. Inflammatory Bowel Dis. 2005, 11, 464-472.
36. Walter, E.; et al. Adenovirus mediated gene transfer to intestinal epithelial cells as a potential approach for oral delivery of peptides and proteins. J. Controlled Release 1997, 46, 75-87.